0555495 - ÚMG 2023 RIV GB eng J - Journal Article
Stavast, C. - van Zuijen, I. - Karkoulia, Eleni - Ozcelik, A. - Van Hoven-Beijen, A. - Leon, L. - Voerman, J.S.A. - Janssen, G. - van Veelen, P. - Burocziová, Monika - Brouwer, R. - van Ijcken, W. - Maas, A. - Bindels, E.M. - van der Velden, V. - Schliehe, C. - Katsikis, P.D. - Alberich-Jorda, Meritxell - Erkeland, S.
The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis.
Leukemia. Roč. 36, č. 3 (2022), s. 687-700. ISSN 0887-6924. E-ISSN 1476-5551
Institutional support: RVO:68378050
Keywords : epithelial-mesenchymal transition * prc2 recruitment * myeloid-leukemia * inhibition * apoptosis * expression * chromatin * micrornas * enhancer * protein
OECD category: Oncology
Impact factor: 11.4, year: 2022
Method of publishing: Open access
https://www.nature.com/articles/s41375-021-01461-5
Permanent Link: http://hdl.handle.net/11104/0330002
Stavast, C. - van Zuijen, I. - Karkoulia, Eleni - Ozcelik, A. - Van Hoven-Beijen, A. - Leon, L. - Voerman, J.S.A. - Janssen, G. - van Veelen, P. - Burocziová, Monika - Brouwer, R. - van Ijcken, W. - Maas, A. - Bindels, E.M. - van der Velden, V. - Schliehe, C. - Katsikis, P.D. - Alberich-Jorda, Meritxell - Erkeland, S.
The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis.
Leukemia. Roč. 36, č. 3 (2022), s. 687-700. ISSN 0887-6924. E-ISSN 1476-5551
Institutional support: RVO:68378050
Keywords : epithelial-mesenchymal transition * prc2 recruitment * myeloid-leukemia * inhibition * apoptosis * expression * chromatin * micrornas * enhancer * protein
OECD category: Oncology
Impact factor: 11.4, year: 2022
Method of publishing: Open access
https://www.nature.com/articles/s41375-021-01461-5
Permanent Link: http://hdl.handle.net/11104/0330002